Delivery Order SPE2DB24D6041-SPE2DB24FKBLC
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract, valued at $2,056.83, is for the delivery of 4,564,559,762 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 100 capsules of the prescription medication Vyvanse 30 mg. The award date is September 16, 2024, with an ultimate completion date of September 17, 2024. The ceiling value of this delivery order is $3,499.78. The contract is a firm fixed-price type and does not have a set-aside designation. Amerisourcebergen is a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,398.42 firm fixed-price contract is for the delivery of 100 units of the prescription medication Vyvanse 30 mg capsules. The delivery order has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,721.25 firm-fixed-price contract is for the supply of 4,565,631,345 units of the pharmaceutical drug Vyvanse (40 mg capsule). The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 firm fixed-price contract is for the delivery of 100 units of the medication Vyvanse 30 mg capsules. The contract has a completion date of June 17, 2025 and is not set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,893.68, is for the supply of 100 units of the 40 mg capsule form of the drug Vyvanse. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, which serve as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,781.26 firm fixed-price contract is for the delivery of Vyvanse 20 mg capsules, a prescription medication. The contract has an ultimate completion date of October 18, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,204.48 firm-fixed-price contract is for the delivery of Vyvanse 30 mg capsules. The contract has an ultimate completion date of February 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,293.00 firm-fixed-price contract is for the delivery of 4,560,447,318 units of the drug Vyvanse 30 mg capsules. The award has an ultimate completion date of April 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,566,108,789 units of the pharmaceutical product Vyvanse 30 mg capsules, at a firm fixed price of $4,351.60. The contract has an ultimate completion date of October 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including an Indefinite Delivery...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB24FKBLCDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $2,713.36 firm-fixed-price contract is for the delivery of 100-count capsules of the medication Vyvanse 30 mg. The ultimate completion date is September 11, 2024, and the award date is September 10, 2024. This contract does not have a set-aside designation. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support various government healthcare programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/10/24 |